Shuhua Yi, Dr
Institute of Hematology & Blood Diseases Hospital, China · Institute of Hematology & Blood Diseases Hospital, Chinese · Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shuhua Yi, Dr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07165769 · Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical TrialInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN · principal investigator
- Ph2NCT06415708 · Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell LymphomaInstitute of Hematology & Blood Diseases Hospital, China · unknown · B Cell Lymphoma · principal investigator
- Ph2NCT05914662 · Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WMInstitute of Hematology & Blood Diseases Hospital, China · unknown · Waldenstrom Macroglobulinemia · principal investigator
- Ph2NCT05846750 · Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone LymphomaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Marginal Zone Lymphoma · principal investigator
- N/ANCT05846763 · Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World StudyInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Follicular Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:57 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.Gastroenterology · 2014595 citationsRCR 22.0
- Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study.Leuk Lymphoma · 2020119 citationsRCR 5.9
- Short-term Outcomes of the Study of Refeeding to Optimize Inpatient Gains for Patients With Anorexia Nervosa: A Multicenter Randomized Clinical Trial.JAMA Pediatr · 202198 citationsRCR 9.1
- Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation.N Engl J Med · 202472 citationsRCR 13.4
- Higher-Calorie Refeeding in Anorexia Nervosa: 1-Year Outcomes From a Randomized Controlled Trial.Pediatrics · 202149 citationsRCR 4.7
- Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.JAMA Netw Open · 20185 citationsRCR 0.3